Viread 250 MG (equivalent to tenofovir disoproxil 204 MG) Oral Tablet
- RxCUI
- 1243229
- RxNorm name
- Viread 250 MG (equivalent to tenofovir disoproxil 204 MG) Oral Tablet
- Display name
- Viread 250 MG (equivalent to tenofovir disoproxil 204 MG) Oral Tablet
- Full name
- Viread 250 MG (equivalent to tenofovir disoproxil 204 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Viread | TENOFOVIR DISOPROXIL FUMARATE | Gilead Sciences, Inc. | 33fd6418-fbdc-42ca-a50d-ce2a476a5418 | 2025-02-18 | Boxed warning, Warnings, Adverse reactions | 1243229 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 33fd6418-fbdc-42ca-a50d-ce2a476a5418 | Viread 250 MG Oral Tablet [PSN] · tenofovir disoproxil fumarate 250 MG Oral Tablet [Viread] [SBD] · Viread 250 MG (equivalent to tenofovir disoproxil 204 MG) Oral Tablet [SY] · Viread 250 MG Oral Tablet [SY] | 4 | 31 | These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 2001 | 20250218 |